Navigation Links
Synvista Therapeutics Highlights Newly Published Data Demonstrating the Value of Haptoglobin Genotype Testing In People with Diabetes
Date:3/5/2008

scribed in this press release, future clinical development of Synvista Therapeutics' product candidates, and other risks identified in Synvista Therapeutics' filings with the Securities and Exchange Commission. Further information on risks faced by Synvista are detailed under the caption "Risk Factors" in Synvista Therapeutics' Annual Report on Form 10-K for the year ended December 31, 2006. These filings are available on a website maintained by the Securities and Exchange Commission at http://www.sec.gov. The information contained in this press release is accurate as of the date indicated. Actual results, events or performance may differ materially. Synvista Therapeutics undertakes no obligation to publicly release the result of any revision to these forward- looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.


'/>"/>
SOURCE Synvista Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Synvista Therapeutics to Present at the 10th Annual BIO CEO & Investor Conference
2. Synvista Therapeutics to Develop Topical Formulation of ALT-2074 for the Treatment of Psoriasis
3. Synvista Therapeutics to be Featured on Wallst.net
4. Synvista Therapeutics to Present at the BIO InvestorForum 2007
5. Cell Therapeutics, Inc. to Hold Conference Call to Update on Recent Transactions and Upcoming Milestones
6. M. Scott Harris, M.D., Joins Ocera Therapeutics, Inc., as Chief Medical Officer
7. CV Therapeutics Reports 2007 Fourth Quarter and Full Year Financial Results
8. TorreyPines Therapeutics to Present at Susquehanna Financial Groups Second Annual SIGnificant Options in Healthcare Conference
9. Hsiao Dee Lieu, M.D., F.A.C.C. Named VP of Clinical Research of Nile Therapeutics
10. The Diabetes Series 2008: Experts Speak About Developing Diabetes Therapeutics
11. CV Therapeutics Announces Presentations at the American College of Cardiology 57th Annual Scientific Session
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... have observed the fractional quantum Hall effect in bilayer ... can be tuned by an electric field. , ... electrons confined to thin sheets are exposed to large ... where thousands of individual electrons behave as a single ... is well established, many details of this collective behavior ...
(Date:7/10/2014)... spiders can sit upside down forever. Nanophysics makes sure of ... an article just published in Physical Review E . ... and spiders that seem to be able to sit still ... for many years. We will soon be able to buy ... gecko,s foot. But the fact is, sooner or later the ...
(Date:7/10/2014)... the University of Illinois at Urbana-Champaign provides new ... of spin and heat at the nanoscale, and ... for data storage and information processing. , ... momentum. In a typical charge current, electrons, spin-angular-momentum ... explained David Cahill, a professor of materials science ...
(Date:1/15/2014)... Using an approach akin to assembling a club ... and Technology (NIST) researchers have succeeded in crafting ... the flammability of foam commonly used in upholstered ... of the nanotube-coated polyurethane foam was reduced 35 ...
Breaking Biology Technology:Columbia researchers observe tunable quantum behavior in bilayer graphene 2Columbia researchers observe tunable quantum behavior in bilayer graphene 3Even geckos can lose their grip 2University of Illinois study advances limits for ultrafast nano-devices 2Layered security: Carbon nanotubes promise improved flame-resistant coating 2
... executives hold high expectations that information technology will reduce ... however.  Earley & Associates, the nation,s foremost information management ... series titled Digitization of the Healthcare Industry ... on Wednesday, May 4 from 1-2 p.m. ...
... 3, 2011 Talecris Biotherapeutics Holdings Corp. (NASDAQ: ... Chapel Hill, N.C., where four proposals were submitted to, and ... the company,s Board of Directors to hold office for a ... and until their successors are elected and qualified. The three ...
... Inc. (Nasdaq: NVAX ) will report financial results ... 2011, before the U.S. financial markets open.  The announcement will ... Stanley C. Erck, President and Chief Executive Officer, and other ... The webcast and conference call will be available ...
Cached Biology Technology:Earley & Associates Offers Two-Part Webinar Series on Challenges and Solutions to Digitization in Healthcare 2Earley & Associates Offers Two-Part Webinar Series on Challenges and Solutions to Digitization in Healthcare 3Talecris Biotherapeutics Announces Results of Annual Stockholders' Meeting 2
(Date:7/11/2014)... researchers at the National Institute of Standards and ... their work more effectively, they often prove that ... was the case recently for M. Lorna De ... the growing specialization of glycomics. Glycomics is the ... glycans that are attached to proteins and lipids ...
(Date:7/11/2014)... Ume University, Sweden, have explored two different ways ... sequence leading to the formation of oxygen molecules ... in the scientific journal Nature Communications . ... day synthetic catalysts for water oxidation, which are ... the direct storage of solar energy in fuels ...
(Date:7/11/2014)... normal circumstances, astrocytes participate in normal physiological ... exhibit therapeutic and repairing effects on brain ... found that nerve cells differentiated from adipose-derived ... viability, which produces influences on subsequent studies ... Hospital, Hebei United University, China demonstrated that ...
Breaking Biology News(10 mins):Molecular snapshots of oxygen formation in photosynthesis 2
... Pathogens , Francisella tularensis , the cause of ... is considered a potential biological weapon because it is readily ... in humans. While a live attenuated vaccine strain has ... to understand the basis for its attenuated virulence. In ...
... Universitt Mnchen (TUM) under Prof. Peter Schieberle and at the ... edible fats and oils: Lard, butterfat, rapeseed oil and olive ... ate 500 grams of low-fat yoghurt enriched with one of ... supplement to their normal diet. "Olive oil had the ...
... series across both genders continue to remain alarmingly low ... patient education and increased public vaccine financing programs are ... Texas Medical Branch (UTMB). The researchers report ... published in Cancer, Human Vaccines & Immunotherapeutics ...
Cached Biology News:News tips from the journal mBio®, volume 4, issue 1 2Olive oil makes you feel full 2HPV vaccine trends point to failures in patient education, vaccine programs 2
The DNA DipStick Kit is ideal for estimating nucleic acid concentrations and approximate yields. Works with ss- and ds-DNA, RNA, and oligonucleotides at concentrations as low as 0.1 ng/l....
Request Info...
... ideal for both radioactive and nonradioactive labeling ... Provides five pre-mixed nucleotide solutions for flexibility ... 8 cpm/g control DNA using [-32P]-dCTP ... performance of the system Labels 1 ...
ABI 432 Resins • Gln(Trt) Peptide Synthesis Column...
Biology Products: